The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Specialty Biopharmaceutical Excipients Market Research Report 2024

Global Specialty Biopharmaceutical Excipients Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1625549

No of Pages : 94

Ask Your Query

Global Specialty Biopharmaceutical Excipients market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Specialty Biopharmaceutical Excipients market research.

Key manufacturers engaged in the Specialty Biopharmaceutical Excipients industry include Merck KGaA, Signet Excipients Pvt. Ltd, Sigachi Industries Limited, Associated British Foods plc, Spectrum Chemical Manufacturing Corp., Roquette Freres, IMCD, Clariant and DFE Pharma, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Specialty Biopharmaceutical Excipients were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Specialty Biopharmaceutical Excipients market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Specialty Biopharmaceutical Excipients market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company (Partial List):

  •     Merck KGaA
  •     Signet Excipients Pvt. Ltd
  •     Sigachi Industries Limited
  •     Associated British Foods plc
  •     Spectrum Chemical Manufacturing Corp.
  •     Roquette Freres
  •     IMCD
  •     Clariant
  •     DFE Pharma
  •     Colorcon
  •     BASF
  •     Evonik Industries
  •     J. RETTENMAIER & SOHNE GmbH

Segment by Type

  •     膨胀剂
  •     溶解度增强剂
  •     表面活性剂
  •     其他

Segment by Application

  •     Oral Medication
  •     Injection Medicine
  •     Other

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

 

The Specialty Biopharmaceutical Excipients report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

 1 Specialty Biopharmaceutical Excipients Market Overview
    1.1 Product Overview and Scope of Specialty Biopharmaceutical Excipients
    1.2 Specialty Biopharmaceutical Excipients Segment by Type
        1.2.1 Global Specialty Biopharmaceutical Excipients Market Value Comparison by Type (2023-2029)
        1.2.2 膨胀剂
        1.2.3 溶解度增强剂
        1.2.4 表面活性剂
        1.2.5 其他
    1.3 Specialty Biopharmaceutical Excipients Segment by Application
        1.3.1 Global Specialty Biopharmaceutical Excipients Market Value by Application: (2023-2029)
        1.3.2 Oral Medication
        1.3.3 Injection Medicine
        1.3.4 Other
    1.4 Global Specialty Biopharmaceutical Excipients Market Size Estimates and Forecasts
        1.4.1 Global Specialty Biopharmaceutical Excipients Revenue 2018-2029
        1.4.2 Global Specialty Biopharmaceutical Excipients Sales 2018-2029
        1.4.3 Global Specialty Biopharmaceutical Excipients Market Average Price (2018-2029)
    1.5 Assumptions and Limitations

 2 Specialty Biopharmaceutical Excipients Market Competition by Manufacturers
    2.1 Global Specialty Biopharmaceutical Excipients Sales Market Share by Manufacturers (2018-2023)
    2.2 Global Specialty Biopharmaceutical Excipients Revenue Market Share by Manufacturers (2018-2023)
    2.3 Global Specialty Biopharmaceutical Excipients Average Price by Manufacturers (2018-2023)
    2.4 Global Specialty Biopharmaceutical Excipients Industry Ranking 2021 VS 2022 VS 2023
    2.5 Global Key Manufacturers of Specialty Biopharmaceutical Excipients, Manufacturing Sites & Headquarters
    2.6 Global Key Manufacturers of Specialty Biopharmaceutical Excipients, Product Type & Application
    2.7 Specialty Biopharmaceutical Excipients Market Competitive Situation and Trends
        2.7.1 Specialty Biopharmaceutical Excipients Market Concentration Rate
        2.7.2 The Global Top 5 and Top 10 Largest Specialty Biopharmaceutical Excipients Players Market Share by Revenue
        2.7.3 Global Specialty Biopharmaceutical Excipients Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

 3 Specialty Biopharmaceutical Excipients Retrospective Market Scenario by Region
    3.1 Global Specialty Biopharmaceutical Excipients Market Size by Region: 2018 Versus 2022 Versus 2029
    3.2 Global Specialty Biopharmaceutical Excipients Global Specialty Biopharmaceutical Excipients Sales by Region: 2018-2029
        3.2.1 Global Specialty Biopharmaceutical Excipients Sales by Region: 2018-2023
        3.2.2 Global Specialty Biopharmaceutical Excipients Sales by Region: 2024-2029
    3.3 Global Specialty Biopharmaceutical Excipients Global Specialty Biopharmaceutical Excipients Revenue by Region: 2018-2029
        3.3.1 Global Specialty Biopharmaceutical Excipients Revenue by Region: 2018-2023
        3.3.2 Global Specialty Biopharmaceutical Excipients Revenue by Region: 2024-2029
    3.4 North America Specialty Biopharmaceutical Excipients Market Facts & Figures by Country
        3.4.1 North America Specialty Biopharmaceutical Excipients Market Size by Country: 2018 VS 2022 VS 2029
        3.4.2 North America Specialty Biopharmaceutical Excipients Sales by Country (2018-2029)
        3.4.3 North America Specialty Biopharmaceutical Excipients Revenue by Country (2018-2029)
        3.4.4 United States
        3.4.5 Canada
    3.5 Europe Specialty Biopharmaceutical Excipients Market Facts & Figures by Country
        3.5.1 Europe Specialty Biopharmaceutical Excipients Market Size by Country: 2018 VS 2022 VS 2029
        3.5.2 Europe Specialty Biopharmaceutical Excipients Sales by Country (2018-2029)
        3.5.3 Europe Specialty Biopharmaceutical Excipients Revenue by Country (2018-2029)
        3.5.4 Germany
        3.5.5 France
        3.5.6 U.K.
        3.5.7 Italy
        3.5.8 Russia
    3.6 Asia Pacific Specialty Biopharmaceutical Excipients Market Facts & Figures by Country
        3.6.1 Asia Pacific Specialty Biopharmaceutical Excipients Market Size by Country: 2018 VS 2022 VS 2029
        3.6.2 Asia Pacific Specialty Biopharmaceutical Excipients Sales by Country (2018-2029)
        3.6.3 Asia Pacific Specialty Biopharmaceutical Excipients Revenue by Country (2018-2029)
        3.6.4 China
        3.6.5 Japan
        3.6.6 South Korea
        3.6.7 India
        3.6.8 Australia
        3.6.9 China Taiwan
        3.6.10 Indonesia
        3.6.11 Thailand
        3.6.12 Malaysia
    3.7 Latin America Specialty Biopharmaceutical Excipients Market Facts & Figures by Country
        3.7.1 Latin America Specialty Biopharmaceutical Excipients Market Size by Country: 2018 VS 2022 VS 2029
        3.7.2 Latin America Specialty Biopharmaceutical Excipients Sales by Country (2018-2029)
        3.7.3 Latin America Specialty Biopharmaceutical Excipients Revenue by Country (2018-2029)
        3.7.4 Mexico
        3.7.5 Brazil
        3.7.6 Argentina
    3.8 Middle East and Africa Specialty Biopharmaceutical Excipients Market Facts & Figures by Country
        3.8.1 Middle East and Africa Specialty Biopharmaceutical Excipients Market Size by Country: 2018 VS 2022 VS 2029
        3.8.2 Middle East and Africa Specialty Biopharmaceutical Excipients Sales by Country (2018-2029)
        3.8.3 Middle East and Africa Specialty Biopharmaceutical Excipients Revenue by Country (2018-2029)
        3.8.4 Turkey
        3.8.5 Saudi Arabia
        3.8.6 UAE

 4 Segment by Type
    4.1 Global Specialty Biopharmaceutical Excipients Sales by Type (2018-2029)
        4.1.1 Global Specialty Biopharmaceutical Excipients Sales by Type (2018-2023)
        4.1.2 Global Specialty Biopharmaceutical Excipients Sales by Type (2024-2029)
        4.1.3 Global Specialty Biopharmaceutical Excipients Sales Market Share by Type (2018-2029)
    4.2 Global Specialty Biopharmaceutical Excipients Revenue by Type (2018-2029)
        4.2.1 Global Specialty Biopharmaceutical Excipients Revenue by Type (2018-2023)
        4.2.2 Global Specialty Biopharmaceutical Excipients Revenue by Type (2024-2029)
        4.2.3 Global Specialty Biopharmaceutical Excipients Revenue Market Share by Type (2018-2029)
    4.3 Global Specialty Biopharmaceutical Excipients Price by Type (2018-2029)

 5 Segment by Application
    5.1 Global Specialty Biopharmaceutical Excipients Sales by Application (2018-2029)
        5.1.1 Global Specialty Biopharmaceutical Excipients Sales by Application (2018-2023)
        5.1.2 Global Specialty Biopharmaceutical Excipients Sales by Application (2024-2029)
        5.1.3 Global Specialty Biopharmaceutical Excipients Sales Market Share by Application (2018-2029)
    5.2 Global Specialty Biopharmaceutical Excipients Revenue by Application (2018-2029)
        5.2.1 Global Specialty Biopharmaceutical Excipients Revenue by Application (2018-2023)
        5.2.2 Global Specialty Biopharmaceutical Excipients Revenue by Application (2024-2029)
        5.2.3 Global Specialty Biopharmaceutical Excipients Revenue Market Share by Application (2018-2029)
    5.3 Global Specialty Biopharmaceutical Excipients Price by Application (2018-2029)

 6 Key Companies Profiled
    6.1 Merck KGaA
        6.1.1 Merck KGaA Corporation Information
        6.1.2 Merck KGaA Description and Business Overview
        6.1.3 Merck KGaA Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2018-2023)
        6.1.4 Merck KGaA Specialty Biopharmaceutical Excipients Product Portfolio
        6.1.5 Merck KGaA Recent Developments/Updates
    6.2 Signet Excipients Pvt. Ltd
        6.2.1 Signet Excipients Pvt. Ltd Corporation Information
        6.2.2 Signet Excipients Pvt. Ltd Description and Business Overview
        6.2.3 Signet Excipients Pvt. Ltd Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2018-2023)
        6.2.4 Signet Excipients Pvt. Ltd Specialty Biopharmaceutical Excipients Product Portfolio
        6.2.5 Signet Excipients Pvt. Ltd Recent Developments/Updates
    6.3 Sigachi Industries Limited
        6.3.1 Sigachi Industries Limited Corporation Information
        6.3.2 Sigachi Industries Limited Description and Business Overview
        6.3.3 Sigachi Industries Limited Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2018-2023)
        6.3.4 Sigachi Industries Limited Specialty Biopharmaceutical Excipients Product Portfolio
        6.3.5 Sigachi Industries Limited Recent Developments/Updates
    6.4 Associated British Foods plc
        6.4.1 Associated British Foods plc Corporation Information
        6.4.2 Associated British Foods plc Description and Business Overview
        6.4.3 Associated British Foods plc Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 Associated British Foods plc Specialty Biopharmaceutical Excipients Product Portfolio
        6.4.5 Associated British Foods plc Recent Developments/Updates
    6.5 Spectrum Chemical Manufacturing Corp.
        6.5.1 Spectrum Chemical Manufacturing Corp. Corporation Information
        6.5.2 Spectrum Chemical Manufacturing Corp. Description and Business Overview
        6.5.3 Spectrum Chemical Manufacturing Corp. Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2018-2023)
        6.5.4 Spectrum Chemical Manufacturing Corp. Specialty Biopharmaceutical Excipients Product Portfolio
        6.5.5 Spectrum Chemical Manufacturing Corp. Recent Developments/Updates
    6.6 Roquette Freres
        6.6.1 Roquette Freres Corporation Information
        6.6.2 Roquette Freres Description and Business Overview
        6.6.3 Roquette Freres Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2018-2023)
        6.6.4 Roquette Freres Specialty Biopharmaceutical Excipients Product Portfolio
        6.6.5 Roquette Freres Recent Developments/Updates
    6.7 IMCD
        6.6.1 IMCD Corporation Information
        6.6.2 IMCD Description and Business Overview
        6.6.3 IMCD Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 IMCD Specialty Biopharmaceutical Excipients Product Portfolio
        6.7.5 IMCD Recent Developments/Updates
    6.8 Clariant
        6.8.1 Clariant Corporation Information
        6.8.2 Clariant Description and Business Overview
        6.8.3 Clariant Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2018-2023)
        6.8.4 Clariant Specialty Biopharmaceutical Excipients Product Portfolio
        6.8.5 Clariant Recent Developments/Updates
    6.9 DFE Pharma
        6.9.1 DFE Pharma Corporation Information
        6.9.2 DFE Pharma Description and Business Overview
        6.9.3 DFE Pharma Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2018-2023)
        6.9.4 DFE Pharma Specialty Biopharmaceutical Excipients Product Portfolio
        6.9.5 DFE Pharma Recent Developments/Updates
    6.10 Colorcon
        6.10.1 Colorcon Corporation Information
        6.10.2 Colorcon Description and Business Overview
        6.10.3 Colorcon Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2018-2023)
        6.10.4 Colorcon Specialty Biopharmaceutical Excipients Product Portfolio
        6.10.5 Colorcon Recent Developments/Updates
    6.11 BASF
        6.11.1 BASF Corporation Information
        6.11.2 BASF Specialty Biopharmaceutical Excipients Description and Business Overview
        6.11.3 BASF Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2018-2023)
        6.11.4 BASF Specialty Biopharmaceutical Excipients Product Portfolio
        6.11.5 BASF Recent Developments/Updates
    6.12 Evonik Industries
        6.12.1 Evonik Industries Corporation Information
        6.12.2 Evonik Industries Specialty Biopharmaceutical Excipients Description and Business Overview
        6.12.3 Evonik Industries Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2018-2023)
        6.12.4 Evonik Industries Specialty Biopharmaceutical Excipients Product Portfolio
        6.12.5 Evonik Industries Recent Developments/Updates
    6.13 J. RETTENMAIER & SOHNE GmbH
        6.13.1 J. RETTENMAIER & SOHNE GmbH Corporation Information
        6.13.2 J. RETTENMAIER & SOHNE GmbH Specialty Biopharmaceutical Excipients Description and Business Overview
        6.13.3 J. RETTENMAIER & SOHNE GmbH Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2018-2023)
        6.13.4 J. RETTENMAIER & SOHNE GmbH Specialty Biopharmaceutical Excipients Product Portfolio
        6.13.5 J. RETTENMAIER & SOHNE GmbH Recent Developments/Updates

 7 Industry Chain and Sales Channels Analysis
    7.1 Specialty Biopharmaceutical Excipients Industry Chain Analysis
    7.2 Specialty Biopharmaceutical Excipients Key Raw Materials
        7.2.1 Key Raw Materials
        7.2.2 Raw Materials Key Suppliers
    7.3 Specialty Biopharmaceutical Excipients Production Mode & Process
    7.4 Specialty Biopharmaceutical Excipients Sales and Marketing
        7.4.1 Specialty Biopharmaceutical Excipients Sales Channels
        7.4.2 Specialty Biopharmaceutical Excipients Distributors
    7.5 Specialty Biopharmaceutical Excipients Customers

 8 Specialty Biopharmaceutical Excipients Market Dynamics
    8.1 Specialty Biopharmaceutical Excipients Industry Trends
    8.2 Specialty Biopharmaceutical Excipients Market Drivers
    8.3 Specialty Biopharmaceutical Excipients Market Challenges
    8.4 Specialty Biopharmaceutical Excipients Market Restraints

 9 Research Finding and Conclusion

 10 Methodology and Data Source
    10.1 Methodology/Research Approach
        10.1.1 Research Programs/Design
        10.1.2 Market Size Estimation
        10.1.3 Market Breakdown and Data Triangulation
    10.2 Data Source
        10.2.1 Secondary Sources
        10.2.2 Primary Sources
    10.3 Author List

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock